2012
DOI: 10.1002/term.1551
|View full text |Cite
|
Sign up to set email alerts
|

A rapid method for obtaining mesenchymal stem cells and platelets from bone marrow aspirate

Abstract: Mesenchymal stem cells (MSCs) and platelet‐rich plasma (PRP) are currently used alone or in combination for therapeutic applications especially for bone repair. We tested whether MSCs can be isolated from bone marrow (BM) aspirate using a commercially available kit commonly used to obtain PRP from peripheral blood (PB). Results revealed that mononuclear cells and platelets from both PB and BM could be efficiently isolated by obtaining a mononuclear and platelet rich fraction (PB‐MPRF and BM‐MPRF, respectively)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 45 publications
0
3
0
Order By: Relevance
“…MSC resulted positive for CD44, CD73, CD90, CD105, CD146 and negative for CD34 and CD45 (17). The multilineage potential was evaluated by differentiation assays as previously described (18). After the appropriate stimulations, cells positively differentiated in osteogenic, adipogenic and condrogenic lineages.…”
Section: Methodsmentioning
confidence: 99%
“…MSC resulted positive for CD44, CD73, CD90, CD105, CD146 and negative for CD34 and CD45 (17). The multilineage potential was evaluated by differentiation assays as previously described (18). After the appropriate stimulations, cells positively differentiated in osteogenic, adipogenic and condrogenic lineages.…”
Section: Methodsmentioning
confidence: 99%
“…Cells for Culture, Xenografts, Cell Therapy, or Single-Cell Analysis.-Needle biopsy to retrieve marrow stem cells is a long-established application. 51 Needle biopsies are increasingly used to retrieve tumor cells for xenograft diagnostic studies. [52][53][54][55][56] Ongoing adequacy issues include retrieval of enough cells with preserved viability.…”
Section: Sample Contains Adequate Materials For Intended Assessmentmentioning
confidence: 99%
“…Translating these techniques into the clinical setting will require the development of a rapid, sterile, one-step technique that could fit into a day surgery timeframe. To date, rapid isolation of bone marrow-derived MSCs [ 9 , 10 ] and their therapeutical potential has been studied [ 11 ], but an important barrier to adoption has been the low number of stem cells requiring a period of cell expansion in the laboratory. There is only one published study assessing a rapid isolation protocol (<30 minutes) for ADMSCs from abdominal lipoaspirate [ 12 ], but even this technique relies on a minimum of 24 hours for plastic adherence.…”
Section: Introductionmentioning
confidence: 99%